Crystal Lake, Illinois, January 2, 2020 - AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.
Quarterly Conference Calls
Press Release (1)
Conference Call (2)
4th Quarter and Annual 2019 Results
February 20, 2020
February 21, 2020, at 8:00 a.m. CT
1st Quarter 2020 Results
April 30, 2020
May 1, 2020, at
8:00 a.m. CT
2nd Quarter 2020 Results
July 30, 2020
July 31, 2020, at
8:00 a.m. CT
3rd Quarter 2020 Results
October 29, 2020
October 30, 2020, at 8:00 a.m. CT
(1) Press releases will be issued on the dates noted after the close of trading on the New York Stock Exchange.
(2) Times shown are in the Central U.S. time zone. Conference calls will last approximately one hour and interested parties are invited to listen to a live webcast by visiting the Investor Relations page of the Aptar website at www.aptar.com. Replay of the conference calls can also be accessed on the Investor Relations page of the website.
Annual Meeting
The Board also announced that the 2020 Annual Meeting of Stockholders will be held at Aptar's corporate headquarters, 265 Exchange Drive, Suite 100, Crystal Lake, Illinois, on May 6, 2020, at 9:00 a.m. CT. The record date for stockholders entitled to vote at the meeting is March 13, 2020.
Download the full press release.
Attachments
Original document
Permalink
Disclaimer
AptarGroup Inc. published this content on 02 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 January 2020 22:31:11 UTC
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.